 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Turning Point Therapeutics Inc. (TPTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-10 Purchase | 2019-09-11 4:15 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 10,000 | $45 | $450,000 | 22,000 (Direct) | View |
| 2019-09-10 Purchase | 2019-09-11 4:16 pm | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 2,222 | $45 | $99,990 | 2,222 (Direct) | View |
| 2019-09-10 Purchase | 2019-09-11 6:42 pm | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 177,777 | $45 | $7,999,965 | 2,170,327 (Indirect) | View |
| 2019-09-10 Purchase | 2019-09-12 4:18 pm | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director | 177,777 | $45 | $7,999,965 | 2,170,327 (Indirect) | View |
| 2019-12-05 Sale | 2019-12-09 8:44 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 118,500 | $51.77 | $6,134,753 | 1,060,719 (Direct Indirect) | View |
| 2019-12-10 Sale | 2019-12-12 7:54 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 34,500 | $53.88 | $1,858,709 | 1,026,219 (Indirect) | View |
| 2019-12-13 Sale | 2019-12-17 9:09 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 41,500 | $58.95 | $2,446,620 | 984,719 (Direct Indirect) | View |
| 2019-12-18 Sale | 2019-12-20 6:29 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 48,500 | $60.92 | $2,954,577 | 936,219 (Direct Indirect) | View |
| 2020-01-10 Sale | 2020-01-14 7:17 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 55,500 | $54.7 | $3,036,046 | 880,719 (Direct Indirect) | View |
| 2020-01-15 Sale | 2020-01-17 5:10 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 11,500 | $53.12 | $610,853 | 869,219 (Direct Indirect) | View |
| 2020-01-27 Sale | 2020-01-29 7:37 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 21,000 | $58.25 | $1,223,284 | 848,219 (Direct Indirect) | View |
| 2020-02-10 Sale | 2020-02-12 7:31 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $64.03 | $3,553,744 | 792,719 (Direct Indirect) | View |
| 2020-02-13 Sale | 2020-02-14 4:22 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $61.84 | $711,137 | 781,219 (Direct Indirect) | View |
| 2020-02-24 Sale | 2020-02-26 8:20 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $52.16 | $1,095,422 | 869,383 (Direct Indirect) | View |
| 2020-03-10 Sale | 2020-03-12 8:40 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 44,000 | $40.84 | $1,796,843 | 825,383 (Direct Indirect) | View |
| 2020-03-23 Sale | 2020-03-25 6:47 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 31,792 | $43.11 | $1,370,451 | 793,591 (Direct Indirect) | View |
| 2020-03-26 Sale | 2020-03-27 6:27 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $46.03 | $529,372 | 782,091 (Direct Indirect) | View |
| 2020-04-06 Sale | 2020-04-08 7:21 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $44.87 | $2,490,476 | 726,591 (Direct Indirect) | View |
| 2020-04-09 Sale | 2020-04-13 7:16 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 12,208 | $47.6 | $581,086 | 714,383 (Direct Indirect) | View |
| 2020-04-22 Sale | 2020-04-24 8:20 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $51.57 | $1,082,979 | 693,383 (Direct Indirect) | View |
| 2020-05-05 Sale | 2020-05-07 6:52 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $53.27 | $2,956,634 | 637,883 (Direct Indirect) | View |
| 2020-05-08 Sale | 2020-05-12 8:09 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $53.86 | $619,351 | 626,383 (Direct Indirect) | View |
| 2020-05-19 Sale | 2020-05-21 7:05 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $59.18 | $1,242,703 | 605,383 (Direct Indirect) | View |
| 2020-05-21 Purchase | 2020-05-26 4:17 pm | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director | 83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) | View |
| 2020-05-21 Purchase | 2020-05-26 5:55 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 4,166 | $60 | $249,960 | 26,872 (Direct) | View |
| 2020-05-21 Purchase | 2020-05-26 5:57 pm | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-13 Option Award | 2019-05-14 4:12 pm | N/A 2029-05-12 | Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director | 30,000 | $29.56 | 30,000 (Direct) | View |
| 2019-05-14 Exercise | 2019-05-16 4:15 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cormorant Asset Management LP Chen Bihua 10% Owner | 23,268 | $2.194 | 0 (Indirect) | View |
| 2019-05-14 Exercise | 2019-05-16 4:15 pm | N/A 2019-07-16 | Turning Point Therapeutics Inc. | TPTX | Cormorant Asset Management LP Chen Bihua 10% Owner | 23,268 | $2.194 | 0 (Indirect) | View |
| 2019-07-24 Option Award | 2019-07-25 4:12 pm | N/A 2029-07-23 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 30,000 | $39.99 | 30,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:27 pm | N/A 2029-08-25 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 312,397 | $54.03 | 312,397 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-03 4:49 pm | N/A 2029-12-01 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 179,192 | $54.73 | 179,192 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:12 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 216 | $31.13 | 50,000 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:12 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 50,000 | $63.33 | 50,000 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:16 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 55,000 | $63.33 | 55,000 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:18 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 33,000 | $63.33 | 33,000 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:20 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 56,000 | $63.33 | 56,000 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:24 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 706 | $31.13 | 325,000 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:24 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 325,000 | $63.33 | 325,000 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-23 4:16 pm | N/A 2030-01-21 | Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director | 25,000 | $59.11 | 25,000 (Direct) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 54,220 | $5.12 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 8,080 | $3.2 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 30,000 | $5.12 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 16,864 | $5.12 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A 2028-11-05 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 54,220 | $5.12 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A 2028-03-08 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 8,080 | $3.2 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A 2028-11-05 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 30,000 | $5.12 | 141,519 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A 2028-11-05 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 16,864 | $5.12 | 141,519 (Indirect) | View |
| 2020-03-02 Option Award | 2020-03-02 7:11 pm | N/A 2030-03-01 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 150,000 | $51.28 | 150,000 (Direct) | View |